91 results on '"Puneet Saxena"'
Search Results
2. Multicenter Case–Control Study of COVID-19–Associated Mucormycosis Outbreak, India
- Author
-
Valliappan Muthu, Ritesh Agarwal, Shivaprakash Mandya Rudramurthy, Deepak Thangaraju, Manoj Radhakishan Shevkani, Atul K. Patel, Prakash Srinivas Shastri, Ashwini Tayade, Sudhir Bhandari, Vishwanath Gella, Jayanthi Savio, Surabhi Madan, Vinay Kumar Hallur, Venkata Nagarjuna Maturu, Arjun Srinivasan, Nandini Sethuraman, Raminder Pal Singh Sibia, Sanjay Pujari, Ravindra Mehta, Tanu Singhal, Puneet Saxena, Varsha Gupta, Vasant Nagvekar, Parikshit Prayag, Dharmesh Patel, Immaculata Xess, Pratik Savaj, Naresh Panda, Gayathri Devi Rajagopal, Riya Sandeep Parwani, Kamlesh Patel, Anuradha Deshmukh, Aruna Vyas, Srinivas Kishore Sistla, Priyadarshini A Padaki, Dharshni Ramar, Saurav Sarkar, Bharani Rachagulla, Pattabhiraman Vallandaramam, Krishna Prabha Premachandran, Sunil Pawar, Piyush Gugale, Pradeep Hosamani, Sunil Narayan Dutt, Satish Nair, Hariprasad Kalpakkam, Sanjiv Badhwar, Kiran Kumar Kompella, Nidhi Singla, Milind Navlakhe, Amrita Prayag, Gagandeep Singh, Poorvesh Dhakecha, and Arunaloke Chakrabarti
- Subjects
Mucormycosis ,Mucorales ,COVID-19 ,Zygomycosis ,invasive molds ,coronavirus disease ,Medicine ,Infectious and parasitic diseases ,RC109-216 - Abstract
We performed a case–control study across 25 hospitals in India for the period of January–June 2021 to evaluate the reasons for an COVID-19–associated mucormycosis (CAM) outbreak. We investigated whether COVID-19 treatment practices (glucocorticoids, zinc, tocilizumab, and others) were associated with CAM. We included 1,733 cases of CAM and 3,911 age-matched COVID-19 controls. We found cumulative glucocorticoid dose (odds ratio [OR] 1.006, 95% CI 1.004–1.007) and zinc supplementation (OR 2.76, 95% CI 2.24–3.40), along with elevated C-reactive protein (OR 1.004, 95% CI 1.002–1.006), host factors (renal transplantation [OR 7.58, 95% CI 3.31–17.40], diabetes mellitus [OR 6.72, 95% CI 5.45–8.28], diabetic ketoacidosis during COVID-19 [OR 4.41, 95% CI 2.03–9.60]), and rural residence (OR 2.88, 95% CI 2.12–3.79), significantly associated with CAM. Mortality rate at 12 weeks was 32.2% (473/1,471). We emphasize the judicious use of COVID-19 therapies and optimal glycemic control to prevent CAM.
- Published
- 2023
- Full Text
- View/download PDF
3. Rare adverse effects of anti tuberculous therapy − a case series
- Author
-
Neeraj Sharma, Kunal Kumar, Sarvinder Singh, Puneet Saxena, Nalin Singh, and Akhil Kollammarukudy Ravi
- Subjects
antituberculous therapy ,drug induced lupus ,thrombocytopenia ,tuberculosis ,pancytopenia ,Diseases of the respiratory system ,RC705-779 - Abstract
Tuberculosis is prevalent throughout the world and is a major public health problem in most developing countries. Standardized and directly observed treatment under NTEP (National Tuberculosis Elimination Programme) is currently recommended for drug-sensitive pulmonary tuberculosis in India. It is generally well tolerated, with few minor side effects. Severe side effects necessitating discontinuation of therapy are rare with standard TB treatment regimens. Drug-resistant tuberculosis (DR-TB) has become more common in recent years, posing a challenge to global efforts to control the disease. Therapy for DR-TB has been associated with many adverse effects. Therefore, close monitoring of patients on DR-TB therapy is necessary to ensure that adverse effects of drugs are recognized early by healthcare personnel and treated accordingly. This will improve drug compliance and, hence, treatment goals. Here we report three cases of tuberculosis who had unusual adverse effects while receiving anti-tuberculous medication, prompting drug discontinuation.
- Published
- 2023
- Full Text
- View/download PDF
4. Spirometry parameters versus forced oscillometry parameters in obstructive airway disease – Is there a correlation?
- Author
-
Priyanka Singh, Puneet Saxena, Nitin B Ahuja, Manu Chopra, Aseem Yadav, and Saurabh Tiwari
- Subjects
Diseases of the respiratory system ,RC705-779 - Published
- 2023
- Full Text
- View/download PDF
5. Impact of HRCT pattern on six-minute walk test in patients with interstitial lung disease—An observational study
- Author
-
Puneet Saxena, Itishree Singh, Abhishek Kumar, S Kartik, Virender Malik, Saurabh Tiwari, K R Akhil, Somali Pattanayak, Vaibhavi G Velangi, and Harsh Jain
- Subjects
exercise test ,forced vital capacity ,interstitial lung disease ,six-minute walk test ,usual interstitial pneumonia ,Diseases of the respiratory system ,RC705-779 - Abstract
Background: Forced vital capacity (FVC) and six-minute walk distance (6MWD) are robust markers in interstitial lung diseases (ILD) to assess severity and prognosis. It is unknown whether high-resolution computed tomography pattern has any independent effect on the exercise capacity in ILD. We compared six-minute walk test (6MWT) parameters between usual interstitial pneumonia (UIP) and non-UIP ILD after adjusting for FVC. Methods: Data from a tertiary care ILD clinic were retrospectively analysed. Based on HRCT, patients were classified as UIP and non-UIP. 6MWT parameters and FVC were recorded for enrolled patients. 6MWD, distance-saturation product (DSP) and exertional desaturation were compared between UIP and non-UIP, using analysis of covariance (ANCOVA), with per cent predicted FVC as covariate. Patients were grouped as mild (≥70%), moderate (51%–69%) and severe (≤50%) based on FVC severity. Results: Out of 169 patients enrolled, only patients with all three data points: spirometry, 6MWT and HRCT were included in the analysis (n = 139). UIP group comprised 56 (40.3%), while non-UIP group had 83 (59.7%) patients. More females and lesser smokers were present in non-UIP group. Mean predicted FVC% was similar between the two HRCT groups (P = 0.611) and had a statistically significant, though very weak to weak correlation with 6MWT parameters {6MWD (r = 0.138); pred 6MWD% (r = 0.170); desaturation (r = -0.227); DSP index (r = 0.166)}. Analysis of covariance showed no statistically significant difference in the 6MWT parameters between UIP and non-UIP groups for similar FVC levels. Conclusion: For a similar level of lung function, exercise capacity was similar for patients with UIP and non-UIP pattern ILD.
- Published
- 2023
- Full Text
- View/download PDF
6. Descriptive study of the role of ultrasound in the evaluation of patients with interstitial lung disease associated with autoimmune connective tissue disorders
- Author
-
Varghese Koshy, Kiran Patel, Deep Yadav, Puneet Saxena, R A George, Vandana Gangadharan, and George Koshy
- Subjects
autoimmune connective tissue disease ,interstitial lung disease ,lung ultrasound ,nonspecific interstitial pneumonitis ,usual interstitial pneumonitis ,Diseases of the musculoskeletal system ,RC925-935 - Abstract
Background and Aim: High-resolution computed tomography (HRCT) of the chest has been the conventionally accepted modality of radiological investigation utilized in the evaluation and management of interstitial lung diseases (ILDs). The aim of this study was to compare the utilization of lung ultrasound (LUS) as a radiological modality versus HRCT scan of the chest, in the diagnosis of cases of ILD in autoimmune connective tissue disease (AICTD) patients at a tertiary care center in Northern India. Methods: In this descriptive study, 42 consecutive diagnosed cases of AICTD with clinical risk of ILD were included, between July 2016 and March 2019, attending the rheumatology outpatient department of CH WC. They were assessed with lung ultrasonography and HRCT chest. Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of LUS were estimated considering HRCT as the reference method. Results: Of these 42 patients, 30 (71.4%) had abnormal LUS findings. HRCT findings suggestive of ILD were seen in 31 (73.8%). Considering HRCT as gold standard, LUS resulted in 01 false-positive and 02 false-negative results. Sensitivity and specificity of LUS with respect to HRCT were 93.55% and 90.91%, respectively. Positive predictive value (PPV) and negative predictive value (NPV) of LUS were calculated at 89.38% and 94.51%, respectively. In 91.6% (11/12) patients with nonspecific interstitial pneumonitis pattern on HRCT, B-lines were found to be numerous and compact (
- Published
- 2023
- Full Text
- View/download PDF
7. Utility and timing of the ROX index in the prediction of high flow oxygen therapy failure in acute hypoxemic respiratory failure of infective etiology: a prospective observational study
- Author
-
Pramod Chaudhari, Pawan Kumar Singh, Manjunath Govindagoudar, Vinod Sharma, Puneet Saxena, Aman Ahuja, Lokesh Lalwani, and Dhruva Chaudhry
- Subjects
High flow oxygen therapy ,respiratory failure ,acute respiratory distress syndrome ,ROX index ,Medicine - Abstract
During and following the COVID-19 pandemic, the world has witnessed a surge in high-flow oxygen therapy (HFOT) use. The ability to provide high oxygenation levels with remarkable comfort levels has been the grounds for the same. Despite the advantages, delay in intubation leading to poor overall outcomes has been noticed in subgroup of patients on HFOT. ROX index has been proposed to be a useful indicator to predict HFOT success. In this study, we have examined the utility of the ROX index prospectively in cases of acute hypoxemic respiratory failure (AHRF) due to infective etiologies. Seventy participants were screened, and 55 were recruited for the study. The majority of participants were males (56.4%), with diabetes mellitus being the most common comorbidity (29.1%). The mean age of the study subjects was 46.27±15.6 years. COVID-19 (70.9%) was the most common etiology for AHRF, followed by scrub typhus (21.8%). Nineteen (34.5%) experienced HFOT failure and 9 (16.4%) subjects died during the study period. Demographic characteristics did not differ between either of the two groups (HFOT success versus failure and survived group versus expired group). ROX index was significantly different between the HFOT success versus failure group at baseline, 2, 4, 6, 12 and 24 h. The best cut-off of ROX index at baseline and 2 h were 4.4 (sensitivity 91.7%, specificity 86.7%) and 4.3 (sensitivity 94.4% and specificity 86.7%), respectively. ROX index was found to be an efficient tool in predicting HFOT failure in cases with AHRF with infective etiology.
- Published
- 2023
- Full Text
- View/download PDF
8. Destabilizers of the thymidylate synthase homodimer accelerate its proteasomal degradation and inhibit cancer growth
- Author
-
Luca Costantino, Stefania Ferrari, Matteo Santucci, Outi MH Salo-Ahen, Emanuele Carosati, Silvia Franchini, Angela Lauriola, Cecilia Pozzi, Matteo Trande, Gaia Gozzi, Puneet Saxena, Giuseppe Cannazza, Lorena Losi, Daniela Cardinale, Alberto Venturelli, Antonio Quotadamo, Pasquale Linciano, Lorenzo Tagliazucchi, Maria Gaetana Moschella, Remo Guerrini, Salvatore Pacifico, Rosaria Luciani, Filippo Genovese, Stefan Henrich, Silvia Alboni, Nuno Santarem, Anabela da Silva Cordeiro, Elisa Giovannetti, Godefridus J Peters, Paolo Pinton, Alessandro Rimessi, Gabriele Cruciani, Robert M Stroud, Rebecca C Wade, Stefano Mangani, Gaetano Marverti, Domenico D'Arca, Glauco Ponterini, and Maria Paola Costi
- Subjects
thymidylate synthase ,protein dimer destabilizers ,cancer growth inhibition ,proteasomal degradation ,enzyme dissociative inhibition mechanism ,target engagement ,Medicine ,Science ,Biology (General) ,QH301-705.5 - Abstract
Drugs that target human thymidylate synthase (hTS), a dimeric enzyme, are widely used in anticancer therapy. However, treatment with classical substrate-site-directed TS inhibitors induces over-expression of this protein and development of drug resistance. We thus pursued an alternative strategy that led us to the discovery of TS-dimer destabilizers. These compounds bind at the monomer-monomer interface and shift the dimerization equilibrium of both the recombinant and the intracellular protein toward the inactive monomers. A structural, spectroscopic, and kinetic investigation has provided evidence and quantitative information on the effects of the interaction of these small molecules with hTS. Focusing on the best among them, E7, we have shown that it inhibits hTS in cancer cells and accelerates its proteasomal degradation, thus causing a decrease in the enzyme intracellular level. E7 also showed a superior anticancer profile to fluorouracil in a mouse model of human pancreatic and ovarian cancer. Thus, over sixty years after the discovery of the first TS prodrug inhibitor, fluorouracil, E7 breaks the link between TS inhibition and enhanced expression in response, providing a strategy to fight drug-resistant cancers.
- Published
- 2022
- Full Text
- View/download PDF
9. Evaluation of Simpler Criteria for Diagnosing Allergic Bronchopulmonary Aspergillosis Complicating Asthma
- Author
-
Ritesh Agarwal, Puneet Saxena, Valliappan Muthu, Inderpaul Singh Sehgal, Sahajal Dhooria, Kuruswamy Thurai Prasad, Ashutosh Nath Aggarwal, and Arunaloke Chakrabarti
- Subjects
allergic bronchopulmonary mycosis (ABPM) ,Aspergillus ,fungal sensitization ,allergy ,latent class analysis (LCA) ,bronchial asthma ,Microbiology ,QR1-502 - Abstract
BackgroundThe modified International Society for Human and Animal Mycology (ISHAM) allergic bronchopulmonary aspergillosis (ABPA) working group (AWG) criteria lists up to five components for diagnosing ABPA in asthmatics. Whether eliminating specific components of the existing criteria would have the same diagnostic utility as the original remains unknown.ObjectiveTo evaluate the performance of several simplified criteria for diagnosing ABPA.MethodsWe compared the performance of seven new criteria (after excluding or modifying one or more of the components of the ISHAM-AWG criteria) with the modified ISHAM-AWG criteria in asthmatic subjects using latent class analysis (LCA). We also tested the performance of the newer criteria using accuracy measures against a multidisciplinary team (MDT) diagnosis of ABPA. We considered the diagnostic accuracy of the newer criteria to be acceptable if the correct classification and false-negative rates were >95% and 95% for three of the seven and
- Published
- 2022
- Full Text
- View/download PDF
10. A Case Series on Neurological Insights of Scrub Typhus
- Author
-
PUNEET SAXENA, DEEPAK CHADHA, and RISHIKA GOYAL
- Subjects
cerebellitis ,febrile illness ,meningoencephalitis ,neurological manifestations ,orientia tsutsugamushi ,rickettsia ,rickettsial diseases ,Medicine - Abstract
Scrub typhus is a rickettsial disease caused by gram negative coccobacilli and transmitted through the bite of larval stage of mite. The disease is notable in the Asia-Pacific belt with few sporadic and epidemic cases reported from India as well. The disease is well identified from North Western part of Rajasthan that are the areas with dense vegetation. The clinical scenario ranges from acute febrile illness to multiple organ dysfunction by virtue of haematogenous seedling. This case series highlights the neurological manifestations of scrub typhus that are diverse and life threatening but holding dearth of literature to convoy appropriately timed diagnosis and treatment.
- Published
- 2020
- Full Text
- View/download PDF
11. A case of hypereosinophilic syndrome with colonic obstruction: An unusual complication
- Author
-
Vikas Marwah, Ashok Rajput, N Thirumoorthi, Sanjeevan Sharma, and Puneet Saxena
- Subjects
Diseases of the respiratory system ,RC705-779 - Published
- 2020
- Full Text
- View/download PDF
12. Exploiting the 2‑Amino-1,3,4-thiadiazole Scaffold To Inhibit Trypanosoma brucei Pteridine Reductase in Support of Early-Stage Drug Discovery
- Author
-
Pasquale Linciano, Alice Dawson, Ina Pöhner, David M. Costa, Monica S. Sá, Anabela Cordeiro-da-Silva, Rosaria Luciani, Sheraz Gul, Gesa Witt, Bernhard Ellinger, Maria Kuzikov, Philip Gribbon, Jeanette Reinshagen, Markus Wolf, Birte Behrens, Véronique Hannaert, Paul A. M. Michels, Erika Nerini, Cecilia Pozzi, Flavio di Pisa, Giacomo Landi, Nuno Santarem, Stefania Ferrari, Puneet Saxena, Sandra Lazzari, Giuseppe Cannazza, Lucio H. Freitas-Junior, Carolina B. Moraes, Bruno S. Pascoalino, Laura M. Alcântara, Claudia P. Bertolacini, Vanessa Fontana, Ulrike Wittig, Wolfgang Müller, Rebecca C. Wade, William N. Hunter, Stefano Mangani, Luca Costantino, and Maria P. Costi
- Subjects
Chemistry ,QD1-999 - Published
- 2017
- Full Text
- View/download PDF
13. Ecthyma gangrenosum like lesions in disseminated mycobacterial tuberculosis infection in a renal transplant recipient
- Author
-
Navjyot Kaur, Aditya Vikram Pachisia, Puneet Saxena, V K Sashindran, and Pankaj Puri
- Subjects
Disseminated mycobacterial tuberculosis infection ,ecthyma gangrenosum-like lesion ,immunocompromised ,Medicine - Abstract
Ecthyma gangrenosum (EG) is a relatively rare skin manifestation that is most commonly described in Pseudomonas aeruginosa bacteremia. It is more frequently seen in immunocompromised individuals. We report a case of 60-year-old renal transplant recipient on triple immunosuppressants and diabetes mellitus type 2 on insulin therapy who developed EG-like lesions due to disseminated mycobacterial tuberculosis (MTB) infection. To the best of our knowledge, this is the first case report of EG-like lesions associated with disseminated kochs.
- Published
- 2017
- Full Text
- View/download PDF
14. Lung cancer in older patients: Age is not just a number!
- Author
-
Pawan Kumar Singh, Dhruva Chaudhry, and Puneet Saxena
- Subjects
Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Published
- 2020
- Full Text
- View/download PDF
15. Bilateral chylothorax as a complication of internal jugular vein cannulation
- Author
-
Puneet Saxena, Subramanian Shankar, Vivek Kumar, and Nardeep Naithani
- Subjects
Bilateral ,central venous catheters ,chylothorax ,complication ,internal jugular vein cannulation ,thoracic duct ,Diseases of the respiratory system ,RC705-779 - Abstract
Central venous catheterization is one of the most prevalent procedures in the Intensive Care Unit. Complications are reported in about 15% of the patients and usually comprise of infection, arterial puncture, malpositioning, pneumothorax, local hematoma, hemothorax, and so on. Chylothorax is a rare complication of this procedure. We present a 42-year-old lady, who developed bilateral massive chylothorax after cannulation of her left internal jugular vein (IJV), due to direct injury to the thoracic duct during the procedure. The patient was successfully managed with bilateral chest tube drainage and omission of oral feeds for four days. Development of bilateral chylothorax as a complication of IJV cannulation is rare, but merits reporting, in view of a large number of central venous cannulations being undertaken. Critical care professionals should be aware of this rare complication of a common procedure to facilitate early identification and institute appropriate therapy.
- Published
- 2015
- Full Text
- View/download PDF
16. Cyclic Peptides Acting as Allosteric Inhibitors of Human Thymidylate Synthase and Cancer Cell Growth
- Author
-
Salvatore Pacifico, Matteo Santucci, Rosaria Luciani, Puneet Saxena, Pasquale Linciano, Glauco Ponterini, Angela Lauriola, Domenico D’Arca, Gaetano Marverti, Remo Guerrini, and Maria Paola Costi
- Subjects
cyclic peptides ,enzyme inhibition ,thymidylate synthase inhibitors ,allosteric inhibitors ,anticancer agents ,ovarian cancer ,Organic chemistry ,QD241-441 - Abstract
Thymidylate synthase (TS) is a prominent drug target for different cancer types. However, the prolonged use of its classical inhibitors, substrate analogs that bind at the active site, leads to TS overexpression and drug resistance in the clinic. In the effort to identify anti-TS drugs with new modes of action and able to overcome platinum drug resistance in ovarian cancer, octapeptides with a new allosteric inhibition mechanism were identified as cancer cell growth inhibitors that do not cause TS overexpression. To improve the biological properties, 10 cyclic peptides (cPs) were designed from the lead peptides and synthesized. The cPs were screened for the ability to inhibit recombinant human thymidylate synthase (hTS), and peptide 7 was found to act as an allosteric inhibitor more potent than its parent open-chain peptide [Pro3]LR. In cytotoxicity studies on three human ovarian cancer cell lines, IGROV-1, A2780, and A2780/CP, peptide 5 and two other cPs, including 7, showed IC50 values comparable with those of the reference drug 5-fluorouracil, of the open-chain peptide [d-Gln4]LR, and of another seven prolyl derivatives of the lead peptide LR. These promising results indicate cP 7 as a possible lead compound to be chemically modified with the aim of improving both allosteric TS inhibitory activity and anticancer effectiveness.
- Published
- 2019
- Full Text
- View/download PDF
17. Price and consumption of tobacco
- Author
-
Virendra Singh, Bharat Bhushan Sharma, Puneet Saxena, Hardayal Meena, and Daya Krishan Mangal
- Subjects
Consumption ,legislation ,plastic sachet ,price ,tobacco sale ,tobacco taxes ,Diseases of the respiratory system ,RC705-779 - Abstract
Background: It is thought that price increase in tobacco products leads to reduced consumption. Though many studies have substantiated this concept, it has not been well studied in India. Recently, price of tobacco products was increased due to ban on plastic sachets of chewing tobacco and increased tax in Rajasthan. This study was designed to evaluate the effect of price rise on overall consumption of tobacco in Jaipur city, Rajasthan. Materials and Methods: This study was carried out in Jaipur city. Two-staged stratified sampling was used. In the first phase of study, cost and consumption of various tobacco products in the months of February and April were enquired from 25 retail tobacco shops. In the second phase, tobacco consumption was enquired from 20 consecutive consumers purchasing any tobacco product from all the above retail tobacco shops. The data were statistically analyzed using descriptive statistics and paired "t" test. Results: The comparison of prices of tobacco products between February and April revealed that the price of cigarette, bidi, and chewing tobacco has increased by 19%, 21%, and 68%, respectively. Average decrease in sales of cigarettes, bidi, and chewing tobacco at shops included in the study were 14%, 23%, and 38%, respectively. The consumers purchasing tobacco also reported decreased consumption. Chewing tobacco showed the maximum reduction (21%). Consumption of cigarette and bidi has also reduced by 15% and 13%, respectively. Conclusion: It may be concluded that reduction in consumption is associated with increased price of tobacco products. Reduced consumption is comparative to the magnitude of price increase.
- Published
- 2012
- Full Text
- View/download PDF
18. Shrinking lung syndrome in systemic lupus erythematosus-scleroderma overlap
- Author
-
Vivek S Guleria, Pradeep K Singh, Puneet Saxena, and Shankar Subramanian
- Subjects
Scleroderma ,scleroderma shrinking lung syndrome ,systemic lupus erythematosus ,Diseases of the respiratory system ,RC705-779 - Abstract
Shrinking lung syndrome (SLS) is a infrequently reported manifestation of systemic lupus erythematosus (SLE). Reported prevalence of SLS is about 0.5% in SLE patients. Pathogenesis is not fully understood and different therapeutic modalities have been employed with variable results, as only 77 cases of SLS have been documented in literature. SLS in SLE-Scleroderma overlap has not been reported yet. We report a patient of SLE - scleroderma overlap presenting with dyspnea, intermittent orthopnea and pleuritic chest pain. Evaluation revealed elevated hemidiaphragms and severe restrictive defect. She was eventually diagnosed as a case of SLS. This case report is a reminder to the medical fraternity that SLS although a rare complication must be thought of in the special subset of patients of SLE having respiratory symptoms.
- Published
- 2014
- Full Text
- View/download PDF
19. Chylothorax, central venous thrombosis and pulmonary infarct in a patient of ovarian germ cell tumor: a case report
- Author
-
Abhishek Sharma, Itishree Singh, Sarvinder Singh, Anvesh Rathore, Puneet Saxena, and Anuradha Ahuja
- Subjects
General Mathematics - Abstract
Background: Extra-abdominal presentations are rarely seen in ovarian germ cell tumors (OGCT). We report a case of a patient with OGCT who presented with systemic venous thrombosis, pulmonary infarct, and chylothorax simultaneously. Case Presentation: A 13-year-old girl presented with dyspnea, fever, and cough of 1 week duration. She was detected to have left-sided chylothorax. Carcinoma Antigen 125 and alpha fetoprotein levels were raised. Computed tomography showed a large ovarian mass, and thrombi in superior vena cava, left brachiocephalic vein, and segmental branch of right pulmonary artery. She also had a peripheral opacity in the right lung with a reverse-halo sign, suggestive of pulmonary infarct. She was diagnosed with yolk-sac tumor and managed with anticoagulation and subsequently neo-adjuvant chemotherapy and surgery. Conclusion: Prothrombotic state in OGCT can lead to systemic thrombosis which may result in chylothorax due to obstruction of thoracic duct. The phenomenon, though rare, should be kept in mind during management of OGCT.
- Published
- 2023
- Full Text
- View/download PDF
20. Tracheobronchopathia osteochondroplastica as an unusual cause of chronic cough
- Author
-
Puneet Saxena, Sarvinder Singh, R.N. Verma, Neeraj Sharma, Kunal Kumar, and Vikram Singh
- Subjects
General Medicine - Published
- 2023
- Full Text
- View/download PDF
21. Multicenter Case-Control Study of COVID-19-Associated Mucormycosis Outbreak, India
- Author
-
Valliappan Muthu, Ritesh Agarwal, Shivaprakash Mandya Rudramurthy, Deepak Thangaraju, Manoj Radhakishan Shevkani, Atul K. Patel, Prakash Srinivas Shastri, Ashwini Tayade, Sudhir Bhandari, Vishwanath Gella, Jayanthi Savio, Surabhi Madan, Vinay Kumar Hallur, Venkata Nagarjuna Maturu, Arjun Srinivasan, Nandini Sethuraman, Raminder Pal Singh Sibia, Sanjay Pujari, Ravindra Mehta, Tanu Singhal, Puneet Saxena, Varsha Gupta, Vasant Nagvekar, Parikshit Prayag, Dharmesh Patel, Immaculata Xess, Pratik Savaj, Naresh Panda, Gayathri Devi Rajagopal, Riya Sandeep Parwani, Kamlesh Patel, Anuradha Deshmukh, Aruna Vyas, Srinivas Kishore Sistla, Priyadarshini A Padaki, Dharshni Ramar, Saurav Sarkar, Bharani Rachagulla, Pattabhiraman Vallandaramam, Krishna Prabha Premachandran, Sunil Pawar, Piyush Gugale, Pradeep Hosamani, Sunil Narayan Dutt, Satish Nair, Hariprasad Kalpakkam, Sanjiv Badhwar, Kiran Kumar Kompella, Nidhi Singla, Milind Navlakhe, Amrita Prayag, Gagandeep Singh, Poorvesh Dhakecha, and Arunaloke Chakrabarti
- Subjects
Microbiology (medical) ,Infectious Diseases ,Epidemiology - Published
- 2022
22. A Delphi consensus statement for the management of post-COVID interstitial lung disease
- Author
-
Vijay Hadda, Tejas M Suri, Hariharan Iyer, Avinash Jain, Saurabh Mittal, Karan Madan, Anant Mohan, Ashu Seith Bhalla, Girish Sindhwani, Naveen Dutt, Kavitha Venkatnarayan, Alok Nath, Sahajal Dhooria, Rohit Kumar, Vikas Marwah, Saurabh Karmakar, Dhruva Chaudhry, Irfan Ismail Ayub, Dharm Prakash Dwivedi, Pawan Tiwari, Parvaiz Koul, Ajoy Kumar Behera, Puneet Saxena, Amitabha Sengupta, Prasanta R Mohapatra, Abhishek Goyal, Devasahayam J Christopher, and Randeep Guleria
- Subjects
Pulmonary and Respiratory Medicine ,Consensus ,Delphi Technique ,Public Health, Environmental and Occupational Health ,Immunology and Allergy ,Humans ,COVID-19 ,Lung Diseases, Interstitial ,Lung - Abstract
As millions of people worldwide recover from COVID-19, a substantial proportion continue to have persistent symptoms, pulmonary function abnormalities, and radiological findings suggestive of post-COVID interstitial lung disease (ILD). To date, there is limited scientific evidence on the management of post-COVID ILD, necessitating a consensus-based approach.A panel of experts in pulmonology and thoracic radiology was constituted. Key questions regarding the management of post-COVID ILD were identified. A search was performed on PubMed and EMBASE and updated till 1 March 2022. The relevant literature regarding the epidemiology, pathophysiology, diagnosis and treatment of post-COVID ILD was summarized. Subsequently, suggestions regarding the management of these patients were framed, and a consensus was obtained using the Delphi approach. Those suggestions which were approved by over 80% of the panelists were accepted. The final document was approved by all panel members.Dedicated facilities should be established for the care of patients with post-COVID ILD. Symptom screening, pulmonary function testing, and thoracic imaging have a role in the diagnosis. The pharmacologic and non-pharmacologic options for the management of post-COVID ILD are discussed. Further research into the pathophysiology and management of post-COVID ILD will improve our understanding of this condition.
- Published
- 2022
23. Author response: Destabilizers of the thymidylate synthase homodimer accelerate its proteasomal degradation and inhibit cancer growth
- Author
-
Luca Costantino, Stefania Ferrari, Matteo Santucci, Outi MH Salo-Ahen, Emanuele Carosati, Silvia Franchini, Angela Lauriola, Cecilia Pozzi, Matteo Trande, Gaia Gozzi, Puneet Saxena, Giuseppe Cannazza, Lorena Losi, Daniela Cardinale, Alberto Venturelli, Antonio Quotadamo, Pasquale Linciano, Lorenzo Tagliazucchi, Maria Gaetana Moschella, Remo Guerrini, Salvatore Pacifico, Rosaria Luciani, Filippo Genovese, Stefan Henrich, Silvia Alboni, Nuno Santarem, Anabela da Silva Cordeiro, Elisa Giovannetti, Godefridus J Peters, Paolo Pinton, Alessandro Rimessi, Gabriele Cruciani, Robert M Stroud, Rebecca C Wade, Stefano Mangani, Gaetano Marverti, Domenico D'Arca, Glauco Ponterini, and Maria Paola Costi
- Published
- 2022
- Full Text
- View/download PDF
24. Prevalence and impact of obstructive sleep apnea in type 2 diabetes mellitus: A descriptive cross-sectional study
- Author
-
Puneet Saxena, Dharmendra Singh, and Yashpal Singh
- Subjects
General Medicine - Published
- 2022
- Full Text
- View/download PDF
25. Assessment of Six-Minute Walk Test Among Discharge-Ready Severe COVID-19 Patients: A Cross-Sectional Study
- Author
-
Uday, Yanamandra, Puneet, Saxena, Rajagopal, Srinath, Anuradha, Sawant, Anurag, Singh, Nupur, Aggarwal, Bareedu, Pavan, Gayatri, Duhan, Bhavya, Aggarwal, and Praneet, Kaur
- Subjects
General Engineering - Abstract
Background Among patients hospitalized for severe pneumonia due to coronavirus disease (COVID-19), clinical stability and normal resting peripheral oxygen saturation (SpO
- Published
- 2022
- Full Text
- View/download PDF
26. Type 1 Renal Tubular Acidosis with Hypokalemic Quadriparesis in Sjogren Syndrome
- Author
-
Keshav, Sharda, Puneet, Saxena, Aradhana, Sharma, and Vipul, Swami
- Subjects
Male ,Sjogren's Syndrome ,Recurrence ,Humans ,Female ,Hypokalemia ,Acidosis, Renal Tubular ,Quadriplegia - Abstract
Sjogren syndrome is an autoimmune disease characterised by lymphocytic infiltration and inflammation of the exocrine glands resulting in decreased secretion of involved glands which manifests mostly as dry eye and dry mouth. The prevalence of the disease is reported to be about 10.3 per 10,000 population. It is more common in females with a male: female ratio of 16:1. Extra glandular manifestations are seen in up to 1/3rd of the cases. Renal involvement is seen in 4.9% of patients with Sjogren syndrome.Here we present three cases of Sjogren Syndrome who presented to our hospital with hypokalaemic quadriparesis.On evaluation all three of the patients were found to have renal tubular acidosis type 1. None of these patients had any symptom of Sjogren syndrome before the onset of quadriparesis. All of these patients had acute onset progressive areflexic quadriparesis with involvement of facial muscles and drooping of eyelids without sensory or bladder bowel involvement. One of these patients had respiratory muscle paralysis severe enough to mandate mechanical ventilation. Arterial Blood Gas analysis and urine electrolyte analysis were suggestive of type 1 renal tubular acidosis. ANA positive in 2 of the 3 patients. Anti-SSAamp; anti-SSB antibodies were positive in all three patients. Supportive measures and IV fluid and electrolyte correction was done. There was complete recovery of power in all three patients and were discharged on oral medications.Renal Tubular Acidosis is characterised by inability of the nephrons to maintain physiologic acid base balance. This usually results from a defect in the tubular transport mechanisms. Distal Renal tubular acidosis (as in these patients) is further defined by an alkalotic urinary pH(gt;5.5) and profound hypokalemia due to impairment in H+ secretion in ditstal tubular alpha-intercalated cells. Owing to this imbalance of ionic transport in distal tubules there can be nephrocalcinosis, nephrolithiasis, rickets and severe muscle weakness. Sjogren syndrome is one of the etiologies leading to development of T1RTA.T1RTA can be the presenting feature of Sjogren Syndrome.Though a rare manifestation of the disease if can be the presenting symptom. Work up for RTA (ABG, urine electrolytes, Urine PH and osmolarity etc) in patients with hypokalaemic paresis can help establish the etiological diagnosis(ANA, anti-SSA,anti-SSB) and help prevent future relapses of the disease.
- Published
- 2022
27. Relationship of Computed Tomography Severity Score With Patient Characteristics and Survival in Hypoxemic COVID-19 Patients
- Author
-
Uday Yanamandra, Shivendra Shobhit, Devashish Paul, Bhavya Aggarwal, Praneet Kaur, Gayatri Duhan, Anurag Singh, Rajagopal Srinath, Puneet Saxena, and Anil S Menon
- Subjects
General Engineering - Abstract
Background Computed tomography (CT) scans and CT severity scores (CTSS) are widely used to assess the severity and prognosis in coronavirus disease 2019 (COVID-19). CTSS has performed well as a predictor in differentiating severe from non-severe cases. However, it is not known if CTSS performs similarly in hospitalized severe cases with hypoxia at admission. Methods We conducted a retrospective comparative study at a COVID-care center from Western India between 25th April and 31st May 2021, enrolling all consecutive severe COVID-19 patients with hypoxemia (peripheral oxygen saturation94%). Neutrophil-lymphocyte ratio (NLR), C-reactive protein (CRP), interleukin-6 (IL-6), lactate dehydrogenase (LDH), D-dimer, ferritin, and CT thorax were done within 24h of admission before being initiated on any anti-COVID-19 therapy. CTSS was calculated by visual assessment and categorized into three severity categories and was correlated with laboratory markers and overall survival (OS). Statistical analysis was done using John's Macintosh Project (JMP) 15.0.0 ver. 3.0.0 (Cary, North Carolina). Results The median age of the study population (n-298) was 59 years (24-95) with a male preponderance (61.41%, n=183). The 15 and 30-day survivals were 67.64% and 59.90%, respectively. CTSS did not correlate with age, gender, time from vaccination, symptoms, or comorbidities but had a significant though weak correlation with LDH (p=0.009), D-dimer (p=0.006), and NLR (p=0.019). Comparing demographic and laboratory aspects using CT severity categories, only NLR (p=0.0146) and D-dimer (p=0.0006) had significant differences. The 15d-OS of mild, moderate, and severe CT categories were 88.62%, 70.39%, and 52.62%, respectively, while 30d-OS of three categories were 59.08%, 63.96%, and 49.12%, respectively. Conclusion Among hospitalized severe COVID-19 patients with hypoxemia at admission, CT severity categories correlate well with outcomes but not inflammatory markers at admission.
- Published
- 2022
28. Definition, diagnosis, and management of COVID-19-associated pulmonary mucormycosis: Delphi consensus statement from the Fungal Infection Study Forum and Academy of Pulmonary Sciences, India
- Author
-
Valliappan Muthu, Ritesh Agarwal, Atul Patel, Soundappan Kathirvel, Ooriapadickal Cherian Abraham, Ashutosh Nath Aggarwal, Amanjit Bal, Ashu Seith Bhalla, Prashant N Chhajed, Dhruva Chaudhry, Mandeep Garg, Randeep Guleria, Ram Gopal Krishnan, Arvind Kumar, Uma Maheshwari, Ravindra Mehta, Anant Mohan, Alok Nath, Dharmesh Patel, Shivaprakash Mandya Rudramurthy, Puneet Saxena, Nandini Sethuraman, Tanu Singhal, Rajeev Soman, Balamugesh Thangakunam, George M Varghese, and Arunaloke Chakrabarti
- Subjects
Infectious Diseases ,Antifungal Agents ,COVID-19 Testing ,Delphi Technique ,COVID-19 ,Humans ,Mucormycosis - Abstract
COVID-19-associated pulmonary mucormycosis (CAPM) remains an underdiagnosed entity. Using a modified Delphi method, we have formulated a consensus statement for the diagnosis and management of CAPM. We selected 26 experts from various disciplines who are involved in managing CAPM. Three rounds of the Delphi process were held to reach consensus (≥70% agreement or disagreement) or dissensus. A consensus was achieved for 84 of the 89 statements. Pulmonary mucormycosis occurring within 3 months of COVID-19 diagnosis was labelled CAPM and classified further as proven, probable, and possible. We recommend flexible bronchoscopy to enable early diagnosis. The experts proposed definitions to categorise dual infections with aspergillosis and mucormycosis in patients with COVID-19. We recommend liposomal amphotericin B (5 mg/kg per day) and early surgery as central to the management of mucormycosis in patients with COVID-19. We recommend response assessment at 4-6 weeks using clinical and imaging parameters. Posaconazole or isavuconazole was recommended as maintenance therapy following initial response, but no consensus was reached for the duration of treatment. In patients with stable or progressive disease, the experts recommended salvage therapy with posaconazole or isavuconazole. CAPM is a rare but under-reported complication of COVID-19. Although we have proposed recommendations for defining, diagnosing, and managing CAPM, more extensive research is required.
- Published
- 2022
29. Evaluation of serum vascular endothelial growth factor (Vegf) and microalbuminuria in early diabetic nephropathy
- Author
-
Rati Mathur, Divya Sharma, and Puneet Saxena
- Subjects
medicine.medical_specialty ,biology ,business.industry ,VEGF receptors ,medicine.disease ,Vascular endothelial growth factor ,Diabetic nephropathy ,chemistry.chemical_compound ,Endocrinology ,chemistry ,Internal medicine ,medicine ,biology.protein ,Microalbuminuria ,business - Published
- 2021
- Full Text
- View/download PDF
30. Study of significance of Serum Cystatin-C and Vascular Endothelial Growth Factor as an early marker of diabetic nephropathy in type 2 diabetes patients
- Author
-
Divya Sharma, Rati Mathur, and Puneet Saxena
- Subjects
Diabetic nephropathy ,Vascular endothelial growth factor ,medicine.medical_specialty ,chemistry.chemical_compound ,Endocrinology ,chemistry ,Serum cystatin ,business.industry ,Internal medicine ,medicine ,Type 2 diabetes ,medicine.disease ,business - Published
- 2021
- Full Text
- View/download PDF
31. Hodgkin Lymphoma presenting as a complex paraneoplastic neurological syndrome in an eventually diagnosed case of Klinefelter Syndrome
- Author
-
Arnab Ghosh, Puneet Saxena, Shashindran Vk, Manish Bhartiya, and Salil Gupta
- Subjects
medicine.medical_specialty ,business.industry ,medicine ,Neurological syndrome ,Hodgkin lymphoma ,Klinefelter syndrome ,medicine.disease ,business ,Dermatology - Published
- 2020
- Full Text
- View/download PDF
32. Ultracentrifugation as a tool for removal of interference caused by lipemia in liver function test
- Author
-
Puneet Saxena and Ajay S Rajput
- Subjects
030213 general clinical medicine ,Analyte ,Chromatography ,biology ,medicine.diagnostic_test ,Chemistry ,Bilirubin ,Significant difference ,Albumin ,030209 endocrinology & metabolism ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Alanine transaminase ,biology.protein ,medicine ,Centrifugation ,Ultracentrifuge ,Liver function tests - Abstract
Introduction: Very often in clinical biochemistry laboratory, lipemic samples are encountered which causes analytical interference in measurement of various biochemistry parameters. In routine practice, 8 to 10 hours of fasting is advised to overcome interference caused by lipemia. To minimize lipemic interference ultracentrifugation, high speed centrifugation, lipid clearing agent, dilution with normal saline or sample blanking can be used. Out of these, u ltracentrifugation is likely to cause least interference as there is minimal exposure to additional chemicals. Aims and Objectives: Aims and objectives of the study were to, identify lipemic samples, analyze liver function test in lipemic samples before ultracentrifugation, perform ultracentrifugation, analyze same analytes after ultracentrifugation and compare the results for any significant statistical and clinical difference. Materials and Methods: From 50 lipemic samples, 2 aliquots were prepared each having 500 microliter of serum. One aliquot was used to perform liver function test. Second aliquot was further subjected to the ultracentrifugation after which the same biochemical parameters were performed. Comparison of results obtained, was done by paired Student’s t-test in Microsoft Office 2007 to assess statically significant difference. Ratio of (lipemic bias in relation to ultracentrifuge samples) to (Biological Variation, CLIA acceptability criteria and laboratory CV %) were also calculated to see whether the difference is clinically significant or not. Results: Statistically significant difference between lipemic and ultracentrifuge samples was observed in alkaline phosphatase, alanine transaminase, total bilirubin, albumin and total protein while only total bilirubin, total protein and alanine transaminase showed clinically significant difference. Conclusions: Ultracentrifugation results in statistically significant difference in results obtained for all parameters of liver function test but clinic
- Published
- 2019
- Full Text
- View/download PDF
33. Radiographical Spectrum of High-altitude Pulmonary Edema: A Pictorial Essay
- Author
-
Uday Yanamandra, Vasu Vardhan, Rajan Grewal, Amul Gupta, Puneet Saxena, Velu Nair, Deepak Mulajkar, and Priyanka Singh
- Subjects
medicine.medical_specialty ,Radiograph ,business.industry ,High-altitude pulmonary edema ,Chest X-ray ,Aspiration Pneumonitis ,Critical Care and Intensive Care Medicine ,medicine.disease ,Malignancy ,Pulmonary edema ,Pulmonary embolism ,Imaging ,Pneumonia ,Heart failure ,medicine ,Original Article ,Radiology ,business ,Cardiopulmonary disease - Abstract
Background High-altitude pulmonary edema (HAPE) is a common cause of hospitalization in high altitude areas with significant morbidity. The clinical presentation of HAPE can overlap with a broad spectrum of cardiopulmonary diseases. Also, it is associated with varied radiological manifestations mimicking other conditions and often leading to unnecessary and inappropriate treatment. Patients and methods The primary aim of the study was to study the various radiological manifestations of HAPE through real-world chest radiographs. We present six different chest X-ray patterns of HAPE as a pictorial assay, at initial presentation, and after the resolution of symptoms with supplemental oxygen therapy and bed rest alone. Results HAPE can present as bilateral symmetrical perihilar opacities, bilateral symmetrical diffuse opacities, unilateral diffuse opacities, bilateral asymmetrical focal opacities, and even lobar consolidation with lower zone or less commonly upper zonal predilection. These presentations can mimic many common conditions like heart failure, acute respiratory distress syndrome, pulmonary embolism, aspiration pneumonitis, pneumonia, malignancy, and tuberculosis. Conclusion A holistic clinical-radiological correlation coupled with analysis of the temporal course can help high-altitude physicians in differentiating true HAPE from its mimics. How to cite this article Yanamandra U, Vardhan V, Saxena P, Singh P, Gupta A, Mulajkar D, et al. Radiographical Spectrum of High-altitude Pulmonary Edema: A Pictorial Essay. Indian J Crit Care Med 2021;25(6):668-674.
- Published
- 2021
34. Disrupters of the Thymidylate Synthase Homodimer Accelerate Its Proteasomal Degradation and Inhibit Cancer Growth
- Author
-
Matteo Santucci, Godefridus J. Peters, Outi M. H. Salo-Ahen, Domenico D'Arca, Matteo Trande, Angela L, Rosaria Luciani, Gabriele Cruciani, Rimessi A, Maria Paola Costi, Silvia Franchini, Cecilia Pozzi, Elisa Giovannetti, Antonio Quotadamo, Stefania Ferrari, Gaia G, Alberto Venturelli, Lorena Losi, Nuno Santarém, Daniela Cardinale, Gaetano Marverti, Emanuele C, Giuseppe Cannazza, Pacifico S, Silvia A, Pasquale Linciano, Stefan H, Anabela Cordeiro-da-Silva, Rebecca C. Wade, Robert M. Stroud, Remo Guerrini, Luca C, Pinton P, Stefano Mangani, Filippo Genovese, Puneet Saxena, and Glauco Ponterini
- Subjects
biology ,Chemistry ,Cancer ,Prodrug ,medicine.disease ,Thymidylate synthase ,Small molecule ,law.invention ,Fluorouracil ,law ,Pancreatic cancer ,Cancer cell ,medicine ,Cancer research ,Recombinant DNA ,biology.protein ,medicine.drug - Abstract
Drugs that target human thymidylate synthase (hTS) are widely used in anti-cancer therapy. However, treatment with classical substrate-site-directed TS inhibitors induces its over-expression and the development of drug resistance. We thus pursued an alternative strategy that led to the discovery of TS-dimer disrupters that bind at the monomer-monomer interface and shift the dimerization equilibrium of both the recombinant and the intracellular protein toward the inactive monomers. We performed a structural, spectroscopic and kinetic investigation of the effects of these small molecules andthe best one, E7, accelerates the proteasomal degradation of hTS in cancer cells. E7 showed a superior anticancer profile to fluorouracil in a mouse model of human pancreatic and ovarian cancer. Thus, over sixty years after the discovery of the first TS prodrug inhibitor, fluorouracil, E7 breaks the link between TS inhibition and enhanced expression in response, providing a strategy to fight drug-resistant cancers.
- Published
- 2021
- Full Text
- View/download PDF
35. A Case Series on Neurological Insights of Scrub Typhus
- Author
-
Rishika Goyal, Puneet Saxena, and Deepak Chadha
- Subjects
medicine.medical_specialty ,rickettsial diseases ,business.industry ,febrile illness ,Clinical Biochemistry ,meningoencephalitis ,General Medicine ,Scrub typhus ,medicine.disease ,bacterial infections and mycoses ,Dermatology ,rickettsia ,neurological manifestations ,medicine ,orientia tsutsugamushi ,Medicine ,business ,cerebellitis - Abstract
Scrub typhus is a rickettsial disease caused by gram negative coccobacilli and transmitted through the bite of larval stage of mite. The disease is notable in the Asia-Pacific belt with few sporadic and epidemic cases reported from India as well. The disease is well identified from North Western part of Rajasthan that are the areas with dense vegetation. The clinical scenario ranges from acute febrile illness to multiple organ dysfunction by virtue of haematogenous seedling. This case series highlights the neurological manifestations of scrub typhus that are diverse and life threatening but holding dearth of literature to convoy appropriately timed diagnosis and treatment.
- Published
- 2020
36. Correction to: Immunotherapy Alone or in Combination with Chemotherapy as First-Line Treatment of Non-Small Cell Lung Cancer
- Author
-
Puneet Saxena, Navneet Singh, Prabhat Singh Malik, and Pawan Kumar Singh
- Subjects
medicine.medical_specialty ,Chemotherapy ,business.industry ,medicine.medical_treatment ,Immunotherapy ,medicine.disease ,First line treatment ,Oncology ,medicine ,Pharmacology (medical) ,Radiology ,Non small cell ,business ,Lung cancer - Abstract
The original version of this article unfortunately contained mistakes. In Table 2, under the column 'Lead to death' in Row 5 [CheckMate-026], the figures should read as '0.7' for Experimental Arm and '1.1' for Comparator. Right now, these are printed as 0.007 and 0.011 respectively.
- Published
- 2020
- Full Text
- View/download PDF
37. Immunotherapy Alone or in Combination with Chemotherapy as First-Line Treatment of Non-Small Cell Lung Cancer
- Author
-
Navneet Singh, Puneet Saxena, Pawan Kumar Singh, and Prabhat Singh Malik
- Subjects
0301 basic medicine ,Oncology ,medicine.medical_specialty ,Lung Neoplasms ,medicine.medical_treatment ,Clinical Decision-Making ,Pembrolizumab ,Gene mutation ,03 medical and health sciences ,0302 clinical medicine ,Antineoplastic Agents, Immunological ,Atezolizumab ,Internal medicine ,Carcinoma, Non-Small-Cell Lung ,Antineoplastic Combined Chemotherapy Protocols ,medicine ,Biomarkers, Tumor ,Anaplastic lymphoma kinase ,Humans ,Pharmacology (medical) ,Epidermal growth factor receptor ,Lung cancer ,Protein Kinase Inhibitors ,Chemotherapy ,biology ,business.industry ,Disease Management ,Immunotherapy ,medicine.disease ,Immune Checkpoint Proteins ,030104 developmental biology ,Treatment Outcome ,030220 oncology & carcinogenesis ,biology.protein ,Disease Susceptibility ,business ,Algorithms - Abstract
Immune checkpoint inhibitors (ICIs) have revolutionized the management of metastatic and selected cases of unresectable advanced non-small cell lung cancer (NSCLC). Importantly for patients, this implies that in the absence of a targetable oncogenic driver [especially epidermal growth factor receptor (EGFR) gene mutations and anaplastic lymphoma kinase (ALK) gene rearrangements] and in the presence of high programmed death-ligand 1 (PD-L1) expression (≥ 50%), they are eligible for mono-therapy with pembrolizumab thereby avoiding chemotherapy as the first line of treatment. This mono-immunotherapy approach for high PD-L1 metastatic NSCLC is associated with improved overall survival (OS) and radiological responses (RR) with lesser toxicity as compared with conventional platinum doublet chemotherapy for both non-squamous and squamous histological types. However, majority of NSCLC patients either have no or low expression of PD-L1 (
- Published
- 2020
38. Identification of potential anti‐hepatitis C virus agents targeting non structural protein 5B using computational techniques
- Author
-
Vinita Vishwakarma, Puneet Saxena, and Prasanthi Polamreddy
- Subjects
0301 basic medicine ,Hepatitis C virus ,Population ,Hepacivirus ,Molecular Dynamics Simulation ,Viral Nonstructural Proteins ,Ligands ,Bioinformatics ,Chronic liver disease ,medicine.disease_cause ,Antiviral Agents ,Biochemistry ,Protein Structure, Secondary ,User-Computer Interface ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,medicine ,Humans ,Fluvastatin ,Olopatadine Hydrochloride ,education ,Molecular Biology ,NS5B ,education.field_of_study ,business.industry ,Drug discovery ,Drug Repositioning ,Computational Biology ,virus diseases ,Hydrogen Bonding ,Cell Biology ,Hepatitis C ,medicine.disease ,digestive system diseases ,Molecular Docking Simulation ,Drug repositioning ,030104 developmental biology ,chemistry ,030211 gastroenterology & hepatology ,Transcriptome ,business ,Hydrophobic and Hydrophilic Interactions ,Allosteric Site ,Metabolic Networks and Pathways ,Protein Binding ,medicine.drug - Abstract
Hepatitis C virus (HCV) nonstructural protein 5B (NS5B) is an RNA-dependent RNA polymerase that plays a key role in HCV replication, and, hence, NS5B is an attractive target for hepatitis C drug discovery. Hepatitis C is a chronic liver disease affecting the global population significantly. Many NS5B inhibitors targeting active site were launched in recent years, however, still there exists a pressing need for cost-effective therapies with pan genotypic activity and therapies targeting niche HCV population with comorbities and resistant to earlier therapies. The objective of the current study is to identify potential anti-HCV agents from FDA approved drugs that are already in the market for a different disease-Drug repurposing approach. A combination of computational chemistry and computational biology techniques was used to discover potential therapies for hepatitis C targeting the NS5B Thumb I allosteric site. Computational chemistry analysis emphasized the fact that fluvastatin, a lipid lowering agent, and olopatadine, an antihistamine, exhibited good binding affinity to NS5B. In addition, gene set enrichment analysis brought to light the significant overlap between disease characteristic features and the mechanism of action of fluvastatin and olopatadine. The current study concludes the potentially beneficial use of fluvastatin in niche hepatitis C patient population suffering from nonalcoholic fatty liver diseases.
- Published
- 2018
- Full Text
- View/download PDF
39. Conformational Propensity and Biological Studies of Proline Mutated LR Peptides Inhibiting Human Thymidylate Synthase and Ovarian Cancer Cell Growth
- Author
-
Matteo Santucci, Simone Vitiello, Marco Mor, Donatella Tondi, Puneet Saxena, Laura Taddia, Gaetano Marverti, Chiara Marraccini, Leda Severi, Sergio Fonda, Remo Guerrini, Stefania Ferrari, Laura Scalvini, Maria Paola Costi, Glauco Ponterini, Domenico D'Arca, Rosaria Luciani, Lorena Losi, and Salvatore Pacifico
- Subjects
0301 basic medicine ,Circular dichroism ,Proline ,Protein Conformation ,Antineoplastic Agents ,Molecular Dynamics Simulation ,medicine.disease_cause ,Thymidylate synthase ,NO ,03 medical and health sciences ,0302 clinical medicine ,Protein structure ,Cell Line, Tumor ,Drug Discovery ,medicine ,Humans ,Enzyme Inhibitors ,Ovarian Neoplasms ,Mutation ,biology ,Cell growth ,Chemistry ,Circular Dichroism ,Thymidylate Synthase ,030104 developmental biology ,Biochemistry ,Cell culture ,030220 oncology & carcinogenesis ,Cancer cell ,biology.protein ,Molecular Medicine ,Female ,Peptides - Abstract
LR and [d-Gln4]LR peptides bind the monomer-monomer interface of human thymidylate synthase and inhibit cancer cell growth. Here, proline-mutated LR peptides were synthesized. Molecular dynamics calculations and circular dichroism spectra have provided a consistent picture of the conformational propensities of the [Pro n]-peptides. [Pro3]LR and [Pro4]LR show improved cell growth inhibition and similar intracellular protein modulation compared with LR. These represent a step forward to the identification of more rigid and metabolically stable peptides.
- Published
- 2018
- Full Text
- View/download PDF
40. Central airway obstruction due to endoluminal tumors: Experience from a tertiary care center in North India
- Author
-
InderpaulS Sehgal, Puneet Saxena, Babu Ram, Sahajal Dhooria, KuruswamyT Prasad, Valliappan Muthu, AshutoshN Aggarwal, and Ritesh Agarwal
- Subjects
Pulmonary and Respiratory Medicine - Published
- 2022
- Full Text
- View/download PDF
41. Anti-Tubercular Therapy Causing Drug Reaction with Eosinophilia and Systemic Symptoms (Dress) Syndrome
- Author
-
Puneet Saxena, Rishika Goyal, and Deepak Chadha
- Subjects
Drug ,Idiosyncratic drug reaction ,medicine.medical_specialty ,business.industry ,media_common.quotation_subject ,Hypersensitivity syndrome ,General Medicine ,medicine.disease ,Dermatology ,Drug reaction with eosinophilia and systemic symptoms ,Education ,Long latency ,Drug induced hypersensitivity ,medicine ,Eosinophilia ,medicine.symptom ,business ,Anti tubercular ,media_common - Abstract
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome is an idiosyncratic drug reaction following a characteristic long latency period. It is previously known as drug induced delayed multiorgan hypersensitivity syndrome (DIDMOHS) or drug induced hypersensitivity (DIHS). The syndrome is manifested by wide range of clinical symptomatology that hold a potential to be life threatening but still is under recognised. The major drugs that cause DRESS syndrome are anticonvulsants, followed by sulfonamides and many anti-in˜ ammatory drugs.Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome is an idiosyncratic drug reaction following a characteristic long latency period. It is previously known as drug induced delayed multiorgan hypersensitivity syndrome (DIDMOHS) or drug induced hypersensitivity (DIHS). The syndrome is manifested by wide range of clinical symptomatology that hold a potential to be life threatening but still is under recognised. The major drugs that cause DRESS syndrome are anticonvulsants, followed by sulfonamides and many anti-inflammatory drugs.
- Published
- 2020
- Full Text
- View/download PDF
42. Rhabdomyolysis in Intensive Care Unit: More than One Cause
- Author
-
Puneet Saxena, Ritesh Agarwal, Kuruswamy Thurai Prasad, Sahajal Dhooria, and Inderpaul Singh Sehgal
- Subjects
medicine.medical_specialty ,Delirium tremens ,Renal failure ,business.industry ,Acute kidney injury ,Tropical myositis ,030208 emergency & critical care medicine ,Case Report ,Critical Care and Intensive Care Medicine ,medicine.disease ,Intensive care unit ,Rhabdomyolysis ,law.invention ,03 medical and health sciences ,0302 clinical medicine ,030228 respiratory system ,law ,medicine ,Etiology ,Intensive care medicine ,business - Abstract
Rhabdomyolysis is a serious medical condition, encountered in the intensive care unit (ICU). The etiology of rhabdomyolysis is often multifactorial. It leads to complications like acute kidney injury and life-threatening electrolyte abnormalities. A high index of suspicion and early institution of therapy is required to prevent complications and improve patient outcomes. Herein, we present the case of a young man with alcohol dependence who presented with fever and altered sensorium. He was found to have rhabdomyolysis and was managed successfully. We also discuss the common causes of rhabdomyolysis and a bedside approach to its management in the ICU. How to cite this article: Saxena P, Dhooria S, Agarwal R, Prasad KT, Sehgal IS. Rhabdomyolysis in Intensive Care Unit: More than One Cause. Indian J Crit Care Med 2019;23(9):427–429.
- Published
- 2019
43. Which Are the Optimal Criteria for the Diagnosis of Allergic Bronchopulmonary Aspergillosis? A Latent Class Analysis
- Author
-
Valliappan Muthu, Mandeep Garg, Kuruswamy Thurai Prasad, Hansraj Choudhary, Inderpaul Singh Sehgal, Puneet Saxena, Ritesh Agarwal, Biman Saikia, Sahajal Dhooria, Ashutosh N. Aggarwal, and Arunaloke Chakrabarti
- Subjects
Thorax ,Adult ,Male ,Vital capacity ,medicine.medical_specialty ,Allergy ,03 medical and health sciences ,FEV1/FVC ratio ,0302 clinical medicine ,Internal medicine ,medicine ,Immunology and Allergy ,Humans ,030212 general & internal medicine ,Asthma ,medicine.diagnostic_test ,business.industry ,Aspergillus fumigatus ,Aspergillosis, Allergic Bronchopulmonary ,Immunoglobulin E ,medicine.disease ,Latent class model ,030228 respiratory system ,Latent Class Analysis ,Female ,Allergic bronchopulmonary aspergillosis ,Chest radiograph ,business - Abstract
Background The ideal criteria for diagnosing allergic bronchopulmonary aspergillosis (ABPA) remain unknown because of the lack of a criterion standard. Latent class analysis using a probabilistic modeling technique can circumvent the need for a reference standard. Objective To compare the diagnostic performance of various criteria used for evaluating ABPA. Methods We prospectively enrolled consecutive cases of bronchial asthma and performed a series of investigations used for the diagnosis of ABPA. We used latent class analysis to analyze the performance of various existing and novel diagnostic criteria. Results Of the 543 subjects (mean age, 37 years; 319 women), 338 (62.2%) and 205 (37.8%) were labeled as “mild-to-moderate” and “severe” asthma cases, respectively. The subjects with severe asthma had a longer duration of asthma and a higher number of exacerbations in the previous year. The prevalence of Aspergillus fumigatus sensitization was 41% and 30%, using the A fumigatus–specific IgE and skin test, respectively. The prevalence of ABPA was 16%, using both the Rosenberg-Patterson and the International Society for Human and Animal Mycology (ISHAM)-ABPA Working Group criteria. The ISHAM criteria were slightly more sensitive (89% vs 81%) and specific (99% vs 98%) than the Patterson criteria. We obtained optimal diagnostic performance by altering the existing ISHAM criteria (serum total IgE >500 international units/mL, excluding the skin test, and using computed tomography of thorax instead of chest radiograph). Conclusions The ISHAM-ABPA Working Group criteria were only marginally better than the Patterson criteria in diagnosing ABPA among patients with asthma younger than 66 years. The diagnostic performance however improved by modifying the prevailing ISHAM criteria, but with increased cost.
- Published
- 2020
44. A rare case report of young onset myelodysplastic syndrome
- Author
-
Rishika, Goyal, Puneet, Saxena, and Aradhana, Sharma
- Subjects
Myelodysplastic Syndromes ,Humans - Published
- 2020
45. A Case Series of Hypokalemic Periodic Paralysis
- Author
-
Deepak, Chadha, Puneet, Saxena, and S S, Dariya
- Subjects
Hypokalemic Periodic Paralysis ,Potassium ,Humans ,Hypokalemia - Published
- 2020
46. Murphy's law in force: sequential adverse events encountered during the treatment of Pneumocystis pneumonia (cotrimoxazole-induced acute peripheral neuropathy and primaquine-induced methemoglobinemia)
- Author
-
Puneet, Saxena, Valliappan, Muthu, Sahajal, Dhooria, Inderpaul Singh, Sehgal, Kuruswamy Thurai, Prasad, and Ritesh, Agarwal
- Subjects
Clindamycin ,Pneumonia, Pneumocystis ,Peripheral Nervous System Diseases ,Primaquine ,Middle Aged ,Anti-Bacterial Agents ,Antimalarials ,Law Enforcement ,Withholding Treatment ,Trimethoprim, Sulfamethoxazole Drug Combination ,Humans ,Drug Therapy, Combination ,Female ,Methemoglobinemia ,Dapsone ,New Zealand - Abstract
Methotrexate monotherapy is a common management strategy in rheumatoid arthritis (RA). Treatment with immunosuppression can lead to opportunistic infections such as Pneumocystis jirovecii pneumonia (PJP). The treatment options for PJP include cotrimoxazole, clindamycin-primaquine and dapsone. Though these drugs are generally well tolerated, they can result in potentially severe adverse effects. Sometimes several undesired events may occur in a single patient, reminding us of Murphy's law. Herein, we report a case which exemplifies this adage. A 50-year-old female developed PJP, while on methotrexate therapy for RA and was treated with cotrimoxazole. The latter resulted in painful peripheral neuropathy, which improved after cotrimoxazole was stopped. Salvage therapy for PJP with primaquine-clindamycin, lead to another serious adverse event, methemoglobinemia. Withdrawing the offending drug resulted in dramatic improvement.
- Published
- 2020
47. Severe Community-Acquired Pneumonia
- Author
-
Sahajal Dhooria, Puneet Saxena, Ritesh Agarwal, and Inderpaul Singh Sehgal
- Subjects
medicine.medical_specialty ,medicine.diagnostic_test ,business.industry ,medicine.drug_class ,Antibiotics ,medicine.disease ,Intensive care unit ,law.invention ,Pneumonia ,Community-acquired pneumonia ,law ,Epidemiology ,Health care ,Risk of mortality ,medicine ,business ,Intensive care medicine ,Chest radiograph - Abstract
Community-acquired pneumonia refers to an infection of the lung parenchyma acquired outside a healthcare setting. The term severe CAP (SCAP) signifies a more serious form of community-acquired pneumonia that requires admission to the intensive care unit and has a high risk of mortality. SCAP is an important cause of morbidity and mortality in both the developed and the developing world. The common causative pathogens of SCAP include pneumococcus, Hemophilus influenzae, and atypical bacterial organisms, and less commonly, gram-negative bacilli and Staphylococcus aureus, particularly in hosts with risk factors for these pathogens. An initial diagnosis can usually be made clinically based on the presentation, and confirmed with the help of a chest radiograph. Scoring systems may be used to assess the severity, mortality risk and requirement of admission to the intensive care unit. Empirical antibiotic treatment must be instituted at the earliest after sending blood and respiratory samples for microbiological analysis and antibiotics may be changed according to the results. Supportive and adjunctive treatments are instituted, as required. Personalized management based on various novel strategies may improve the management of SCAP in the future. In this chapter, we present a detailed discussion of the epidemiology, pathogenesis, diagnostic evaluation and treatment of SCAP.
- Published
- 2020
- Full Text
- View/download PDF
48. To Evaluate the Association of Neck Circumference with Metabolic Syndrome and Cardiovascular Risk Factors
- Author
-
Rajesh Kumar, Bochaliya, Aradhna, Sharma, Puneet, Saxena, G D, Ramchandani, and Girish, Mathur
- Subjects
Adult ,Male ,Metabolic Syndrome ,Biometry ,Adolescent ,Middle Aged ,Young Adult ,Cardiovascular Diseases ,Risk Factors ,Obesity, Abdominal ,Humans ,Female ,Waist Circumference ,Neck - Abstract
It is accepted that metabolic syndrome increases the relative risk of cardiovascular disease and visceral adiposity lies at root of the cardio-metabolic risk. Upper body fat distribution has long been recognized as associated with metabolic syndrome and increased cardiovascular risk; hence the present study was conducted with the objective to evaluate the association of neck circumference with metabolic syndrome and cardiovascular risk factors.The present study was a hospital based observational, Descriptive and comparative analysis, conducted at Department of General Medicine at a tertiary care centre of west India after Ethical clearance from the institute's ethical committee and written informed consent. A total of 405 subjects aged 18 - 60 years were selected consecutively after inclusion and exclusion criteria. Subjects were evaluated for metabolic syndrome components and cardiovascular risk factors. Neck circumference of ≥ 37 cm in males and ≥ 34 cm in females was considered abnormal.Metabolic syndrome was seen in 189 (46.7%) subjects. Raised triglyceride level was the most common (52.8%) component. Neck circumference was found to be statistically significant associated with metabolic syndrome (p0.001) as well as cardiovascular risk factors like BMI, Waist circumference, Hypertension, Fasting blood sugar, TG and HDL were also found to be statistically significant associated with neck circumference.Neck Circumference can be used as a sensitive tool for metabolic syndrome and cardiovascular risk factors. Patients with abnormal Neck circumference should be screened for cardiovascular risk factors to detect abnormality for early and appropriate intervention.
- Published
- 2019
49. Lung cancer in older patients: Age is not just a number!
- Author
-
Puneet Saxena, Dhruva Chaudhry, and PawanKumar Singh
- Subjects
medicine.medical_specialty ,Older patients ,business.industry ,Internal medicine ,medicine ,General Medicine ,Lung cancer ,medicine.disease ,business ,lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,lcsh:RC254-282 - Published
- 2020
50. Hotspots in an Obligate Homodimeric Anticancer Target. Structural and Functional Effects of Interfacial Mutations in Human Thymidylate Synthase
- Author
-
Daniela Cardinale, Maria Paola Costi, Puneet Saxena, Outi M. H. Salo-Ahen, Cecilia Pozzi, Hannu Myllykallio, Stefano Mangani, Rebecca C. Wade, Robert M. Stroud, Anna Tochowicz, Yap Boum, Glauco Ponterini, and Stefania Ferrari
- Subjects
Protein Conformation ,Dimer ,Mutant ,Antineoplastic Agents ,dissociation ,hot-spot, dimeric enzyme, thymidylate synthase, anticancer, FRET ,Article ,chemistry.chemical_compound ,Protein structure ,hot spot ,Neoplasms ,Drug Discovery ,Medicine and Health Sciences ,Humans ,Point Mutation ,tymidylate synthase, hot spot, FRET, x-ray crystallography, inhibition, dissociation, dimer interface ,Enzyme Inhibitors ,dimer interface ,x-ray crystallography ,Alanine ,biology ,Chemistry ,Point mutation ,Active site ,Thymidylate Synthase ,tymidylate synthase ,Small molecule ,inhibition ,Enzyme Activation ,Molecular Docking Simulation ,Förster resonance energy transfer ,Biochemistry ,FRET ,biology.protein ,Molecular Medicine ,Protein Multimerization - Abstract
Human thymidylate synthase (hTS), a target for antiproliferative drugs, is an obligate homodimer. Single-point mutations to alanine at the monomer–monomer interface may enable the identification of specific residues that delineate sites for drugs aimed at perturbing the protein–protein interactions critical for activity. We computationally identified putative hotspot residues at the interface and designed mutants to perturb the intersubunit interaction. Dimer dissociation constants measured by a FRET-based assay range from 60 nM for wild-type hTS up to about 1 mM for single-point mutants and agree with computational predictions of the effects of these mutations. Mutations that are remote from the active site retain full or partial activity, although the substrate KM values were generally higher and the dimer was less stable. The lower dimer stability of the mutants can facilitate access to the dimer interface by small molecules and thereby aid the design of inhibitors that bind at the dimer interface.Graphical abstract
- Published
- 2015
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.